CLASS III Drug recall · Reported 1 Nov 2017 · FDA Enforcement Report

Enalapril Maleate tablets, USP, 5mg recalled by Wockhardt Usa

Wockhardt Usa is recalling Enalapril Maleate tablets, USP, 5mg, distributed nationwide in the US. The recall was initiated on 22 Aug 2017 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # DR10635, EXP 05/2019; DR10636, EXP 05/2019.
Quantity recalled5050 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0051-2018
FDA event ID
77951
Recalling firm
Wockhardt Usa, Parsippany, NJ
Classification
Class III
Status
Terminated
Recall initiated
22 Aug 2017
FDA classified
26 Oct 2017
Reported
1 Nov 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

22 Aug 2017Recall initiated by company
26 Oct 2017Classified by FDA+65 days
1 Nov 2017Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications: 5mg strength being recalled for out of specification results for related compound.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Enalapril Maleate tablets, USP, 5mg, 1000-count bottles, Rx only, Manufactured by: Wockhardt Limited H-14/2, M.I.D.C. Area, Waluj, Aurangabad, Maharashtra, India, Distributed by: Wockhardt, USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054, USA. NDC: 64679-924-03;

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications: 5mg strength being recalled for out of specification results for related compound.

Which lots are affected?

Lot # DR10635, EXP 05/2019; DR10636, EXP 05/2019.

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Wockhardt Usa

All 45

Other Enalapril recalls

All 21